Tango Therapeutics, Inc. (TNGX)

Data as of Oct 5, 2026, from SEC Form 4 filings.

Net insider selling (90d)Watch TNGX

See up to 3 months of TNGX. The 7-day demo opens the 1M and 3M ranges and puts TNGX on your watchlist.

Latest TNGX insider trades

Adam Crystal - Officer
Open-market sale$646K
Oct 1, 2026
Adam Crystal - Officer

About Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. files with the SEC under CIK 0001819133 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for TNGX on EDGAR

TNGX Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	5	81,000	$2.00M
Option exercise	6	162,000

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

TNGX insider transactions (Form 4)

35 Form 4 filings on record, the earliest from Oct 23, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Oct 1, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
Oct 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	26,400	$24.45^{footnote F2}	$646K
Oct 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	600	$25.32^{footnote F3}	$15K
Oct 1, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $23.96 to $24.95 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $25.04 to $25.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Sep 1, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
Sep 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	27,000	$22.37^{footnote F2}	$604K
Sep 1, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $22.08 to $22.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Aug 3, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
Aug 3, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	5,267	$26.79^{footnote F2}	$141K
Aug 3, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	21,733	$27.35^{footnote F3}	$594K
Aug 3, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $26.17 to $27.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $27.17 to $27.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Jul 1, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
Jul 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	19,629	$29.34^{footnote F2}	$576K
Jul 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	7,371	$30.25^{footnote F3}	$223K
Jul 1, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $28.715 to $29.71 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $29.72 to $30.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Jun 19, 2026	Robert Azelby	Grant or award	Common Stock	5,740^{footnote F1}	$0.00	-
Jun 19, 2026	Robert Azelby	Grant or award	Stock Option (Right to Buy)	35,910	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting… Full note on SEC EDGAR
Jun 5, 2026	John B. Ketchum	Grant or award	Common Stock	4,000^{footnote F1}	$0.00	-
Jun 5, 2026	John B. Ketchum	Grant or award	Stock Option (Right to Buy)	25,000	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting… Full note on SEC EDGAR
Jun 5, 2026	Lesley Ann Calhoun	Grant or award	Common Stock	4,000^{footnote F1}	$0.00	-
Jun 5, 2026	Lesley Ann Calhoun	Grant or award	Stock Option (Right to Buy)	25,000	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting… Full note on SEC EDGAR
Jun 5, 2026	Mace Rothenberg	Grant or award	Common Stock	4,000^{footnote F1}	$0.00	-
Jun 5, 2026	Mace Rothenberg	Grant or award	Stock Option (Right to Buy)	25,000	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting… Full note on SEC EDGAR
Jun 5, 2026	Sung Lee	Grant or award	Common Stock	570^{footnote F1}	$0.00	-
Jun 5, 2026	Sung Lee	Grant or award	Stock Option (Right to Buy)	3,570	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting… Full note on SEC EDGAR
Jun 1, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
Jun 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	6,140	$22.25^{footnote F2}	$137K
Jun 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	20,860	$23.06^{footnote F3}	$481K
Jun 1, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $21.58 to $22.57 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $22.60 to $23.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
May 1, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
May 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	25,900	$21.19^{footnote F3}	$549K
May 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	1,100	$22.00^{footnote F4}	$24K
May 1, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $20.79 to $21.755 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $21.80 to $22.20 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
May 1, 2026	Matthew Gall - Officer	Grant or award	Common Stock	40,000^{footnote F1}	$0.00	-
May 1, 2026	Matthew Gall - Officer	Grant or award	Stock Option (Right to Buy)	240,000	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest over a three-year period at a rate of (i) 13,200 RSUs on or about May 10, 2027, (ii) 13,200 RSUs on… Full note on SEC EDGAR
Apr 29, 2026	Sung Lee	Grant or award	Common Stock	12,300^{footnote F1}	$0.00	-
Apr 29, 2026	Sung Lee	Grant or award	Stock Option (Right to Buy)	5,200	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on January 2, 2027, January 2, 2028 and January 2… Full note on SEC EDGAR
Apr 15, 2026	Adam Crystal - Officer	Option exercise	Common Stock	38,460	$5.20	$200K
Apr 15, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	38,460	$25.00	$962K
Apr 15, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	38,460	$0.00	-
Apr 1, 2026	Adam Crystal - Officer	Option exercise	Common Stock	27,000	$5.20	$140K
Apr 1, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	27,000	$21.20^{footnote F2}	$572K
Apr 1, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	27,000	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Mar 25, 2026	Adam Crystal - Officer	Option exercise	Common Stock	12,000	$5.20	$62K
Mar 25, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	12,000	$20.11^{footnote F2}	$241K
Mar 25, 2026	Adam Crystal - Officer	Option exercise	Stock Option (Right to Buy)	12,000	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Mar 5, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	20,251	$15.00	$304K
Feb 25, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	54,345	$12.77^{footnote F2}	$694K
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $12.61 to $13.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Feb 2, 2026	Daniella Beckman - Officer	Grant or award	Common Stock	44,330^{footnote F1}	$0.00	-
Feb 3, 2026	Daniella Beckman - Officer	Open-market sale	Common Stock	10,204	$12.26^{footnote F3}	$125K
Feb 3, 2026	Daniella Beckman - Officer	Open-market sale	Common Stock	113	$12.90^{footnote F4}	$1K
Feb 2, 2026	Daniella Beckman - Officer	Grant or award	Stock Option (Right to Buy)	265,980	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Feb 2, 2026	Barbara Weber - Officer	Grant or award	Common Stock	37,522^{footnote F1}	$0.00	-
Feb 3, 2026	Barbara Weber - Officer	Open-market sale	Common Stock	30,186	$12.26^{footnote F3}	$370K
Feb 3, 2026	Barbara Weber - Officer	Open-market sale	Common Stock	333	$12.90^{footnote F4}	$4K
Feb 2, 2026	Barbara Weber - Officer	Grant or award	Stock Option (Right to Buy)	222,132	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in full on February 1, 2027, subject to the Reporting Person's continuous service with the Issuer as… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Feb 2, 2026	Adam Crystal - Officer	Grant or award	Common Stock	47,460^{footnote F1}	$0.00	-
Feb 3, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	18,251	$12.26^{footnote F3}	$224K
Feb 3, 2026	Adam Crystal - Officer	Open-market sale	Common Stock	201	$12.90^{footnote F4}	$3K
Feb 2, 2026	Adam Crystal - Officer	Grant or award	Stock Option (Right to Buy)	284,760	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Jan 8, 2026	Malte Peters - Officer	Grant or award	Common Stock	350,000^{footnote F1}	$0.00	-
Jan 8, 2026	Malte Peters - Officer	Grant or award	Stock Option (Right to Buy)	1,650,000	$0.00	-
Footnote F1 (shares): These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on… Full note on SEC EDGAR
Jan 2, 2026	Sung Lee	Grant or award	Common Stock	10,000	$0.00	-
Jan 2, 2026	Sung Lee	Grant or award	Stock Option (Right to Buy)	60,000	$0.00	-
Nov 3, 2025	Malte Peters	Grant or award	Stock Option (Right to Buy)	150,000	$0.00	-
Oct 23, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	477,401	$10.15^{footnote F1}	$4.85M
Footnote F1 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR
Sep 25, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	500,000	$8.02	$4.01M
Sep 16, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	363,541	$7.04	$2.56M
Sep 5, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	642,906	$7.00	$4.50M
Sep 8, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	86,459	$7.04	$609K
Aug 22, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	302,194	$7.00	$2.12M
Aug 19, 2025	Third Rock Ventures IV, L.P.	Open-market sale	Common Stock	1,100,000	$7.01	$7.71M

Recent TNGX Form 8-K filings

Read TNGX company news

Aug 11, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Aug 11, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Aug 7, 2026Item 5.02, 7.01, 9.01

Read the filing on SEC EDGAR

Aug 6, 2026Item 5.02

Recent TNGX Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 22, 2026	Jessica Newcomb	Officer	15,231	$340K	View on EDGAR
Aug 3, 2026	ADAM CRYSTAL	Officer	81,000	$2.20M

TNGX insider trading FAQ

What is the latest insider trade for TNGX?

Tango Therapeutics, Inc. (TNGX) had 3 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for TNGX runs to 35 Form 4 filings, the earliest from 2024-10-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying TNGX stock?

No insider purchases of TNGX were filed in the last 90 days. 2 purchases are on record for this company.

How many insiders are selling TNGX stock?

5 insider sales of TNGX were filed in the last 90 days, totaling $2.00M.

Where can I see TNGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects TNGX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 5, 2026 - Adam Crystal view on EDGAR
Sep 3, 2026 - Adam Crystal view on EDGAR
Aug 5, 2026 - Adam Crystal view on EDGAR
Jul 2, 2026 - Adam Crystal view on EDGAR
Jun 23, 2026 - Robert Azelby view on EDGAR
Jun 8, 2026 - John B. Ketchum view on EDGAR
Jun 8, 2026 - Lesley Ann Calhoun view on EDGAR
Jun 8, 2026 - Mace Rothenberg view on EDGAR
Jun 8, 2026 - Sung Lee view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where TNGX's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow TNGX with a 7-day demo

TNGX on your watchlist
Every TNGX Form 4 filing on record
Up to 3 months of TNGX price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

81,000

$2.00M

Option exercise

162,000

Date

Insider

Transaction

Security

Price

Value

Oct 1, 2026